Protection of free-living and captive possums against pulmonary challenge with Mycobacterium bovis following oral BCG vaccination

Tuberculosis

Volumn 89, Issue 2, 2009, Pages 163-168

  Ramsey, D S L ^a   Aldwell, F E ^b   Cross, M L ^b   de Lisle, G W ^c   Buddle, B M ^d  

^a LANDCARE RESEARCH   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c AGRESEARCH   (New Zealand)

^d AGRESEARCH GRASSLANDS   (New Zealand)

Author keywords

BCG; Mycobacterium bovis; Oral vaccine; Possum; Survival analysis; Wildlife

Indexed keywords

BCG VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BCG VACCINATION; BOVINE TUBERCULOSIS; CONTROLLED STUDY; FEMALE; MALE; MORTALITY; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TRICHOSURUS; TRICHOSURUS VULPECULA; ANIMAL; ANIMAL HUSBANDRY; DISEASE CARRIER; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TUBERCULOSIS, PULMONARY; VACCINATION; VETERINARY;

ADMINISTRATION, ORAL; ANIMAL HUSBANDRY; ANIMALS; BCG VACCINE; DISEASE RESERVOIRS; FEMALE; LUNG; MALE; MYCOBACTERIUM BOVIS; SURVIVAL ANALYSIS; TRICHOSURUS; TUBERCULOSIS, PULMONARY; VACCINATION;

EID: 61649109753     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2008.11.002     Document Type: Article

References (33)

1. Ryan T.J., Livingstone P.G., Ramsey D.S., de lisle G.W., Nugent G., Collins D.M., et al. Advances in understanding disease epidemiology and implications for control and eradication of tuberculosis in livestock: the experience from New Zealand. Vet Microbiol 112 (2006) 211-219
2. Jackson R., Cooke M.M., Coleman J.D., and Morris R.S. Naturally occurring tuberculosis caused by Mycobacterium bovis in brushtail possums (Trichosurus vulpecula): I. An epidemiological analysis of lesion distribution. N Z Vet J 43 (1995) 306-314
3. Ramsey D., and Cowan P. Mortality rate and movements of brushtail possums with clinical tuberculosis (Mycobacterium bovis) infection. N Z Vet J 51 (2003) 179-185
4. Barlow N.D. A spatially aggregated disease/host model for bovine Tb in New Zealand possum populations. J Appl Ecol 28 (1991) 777-793
5. Coleman J., Caley P. Possums as a reservoir of bovine Tb. In: Montague T.L., editor. The brushtail possum. Biology, impact and management of an introduced marsupial. Lincoln, New Zealand: Manaaki Whenua Press; p. 47-61.
6. Livingstone P.G., Ryan T.J., Hancox N., Crews K.B., Bosson M.A.J., and Knowles G.J.E. Regionalisation: a strategy for facilitating trade and assisting with bovine tuberculosis control. Vet Microbiol 112 (2006) 291-301
7. Corner L.A., Norton S., Buddle B.M., and Morris R.S. The efficacy of bacille Calmette-Guerin vaccine in wild brushtail possums (Trichosurus vulpecula). Res Vet Sci 73 (2002) 145-152
8. Aldwell F.E., Keen D.L., Stent V.C., Thomson A., Yates G.F., de Lisle G.W., et al. Route of BCG administration in possums affects protection against bovine tuberculosis. N Z Vet J 43 (1995) 356-359
9. Buddle B.M., Aldwell F.E., Keen D.L., Parlane N.A., Yates G., and de Lisle G.W. Intraduodenal vaccination of brushtail possums with bacille Calmette-Guerin enhances immune responses and protection against Mycobacterium bovis infection. Int J Tuberc Lung Dis 1 (1997) 377-383
10. Aldwell F.E., Keen D.L., Parlane N.A., Skinner M.A., de Lisle G.W., and Buddle B.M. Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums. Vaccine 22 (2003) 70-76
11. Buddle B.M., Aldwell F.E., Keen D.L., Parlane N.A., Hamel K.L., and de Lisle G.W. Oral vaccination of brushtail possums with BCG: investigation into factors that may influence vaccine efficacy and determination of duration of protection. N Z Vet J 54 (2006) 224-230
12. Cross M.L., and Aldwell F.E. A perspective of oral vaccination against bovine tuberculosis with Mycobacterium bovis BCG. Expert Rev Vaccines 6 (2007) 323-331
13. Aldwell F.E., Pfeffer A., DeLisle G.W., Jowett G., Heslop J., Keen D., et al. Effectiveness of BCG vaccination in protecting possums against bovine tuberculosis. Res Vet Sci 58 (1995) 90-95
14. Aldwell F.E., Baird M.A., Fitzpatrick C.E., McLellan A.D., Cross M.L., Lambeth M.R., et al. Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: anatomical sites of bacterial replication and immune activity. Immunol Cell Biol 83 (2005) 549-553
15. Collins D.M., de Lisle G.W., Aldwell F.E., and Buddle B.M. A new attenuated Mycobacterium bovis vaccine protects brushtail possums (Trichosurus vulpecula) against experimental tuberculosis infection. Vaccine 25 (2007) 4659-4664
16. Aldwell F.E., Tucker I.G., de Lisle G.W., and Buddle B.M. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice. Infect Immun 71 (2003) 101-108
17. McMurray D.N. Determinants of vaccine-induced resistance in animal models of pulmonary tuberculosis. Scand J Infect Dis 33 (2001) 175-178
18. Horwitz M.A., and Harth G. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect Immun 71 (2003) 1672-1679
19. Buddle B.M., Aldwell F.E., Pfeffer A., and de Lisle G.W. Experimental Mycobacterium bovis infection in the brushtail possum (Trichosurus vulpecula): pathology, haematology and lymphocyte stimulation responses. Vet Microbiol 38 (1994) 241-254
20. Ramsey D., Efford M., Cowan P., and Coleman J. Factors influencing annual variation in breeding by common brushtail possums (Trichosurus vulpecula) in New Zealand. Wildl Res 29 (2002) 39-50
21. Efford M.G. Demographic consequences of sex-biased dispersal in a population of brushtail possums. J Anim Ecol 67 (1998) 503-517
22. Cowan P.E., and White A.J. Evaluation of tooth-wear age index for brushtail possums, Trichosurus vulpecula. Austr Wildl Res 16 (1989) 321-322
23. Skinner M.A., Keen D.L., Parlane N.A., Yates G.F., and Buddle B.M. Increased protection against bovine tuberculosis in the brushtail possum (Trichosurus vulpecula) when BCG is administered with killed Mycobacterium vaccae. Tuberculosis (Edinb) 82 (2002) 15-22
24. Burnham K.P., and Anderson D.R. Model selection and inference: a practical information-theoretic approach (1998), Springer-Verlag, New York
25. Schoenfeld D. Chi-squared goodness-of-fit tests for the proportional hazards regression. Biometrika 67 (1980) 145-153
26. Lesellier S, Corner LA, Chambers MA, Aldwell FE, Costello E, Sleeman DP, et al. Oral vaccination of badgers (Meles meles) against tuberculosis: immune responses and protection following BCG delivery via the oral route and pulmonary challenge with Mycobacterium bovis. In: Proceedings of the Wildlife Disease Association 55th annual meeting (2006). Wildlife Disease Association online publication, URL: http://www.wildlifedisease.org/Documents/Proceedings/Storrs_06.pdf.
27. Clark S., Cross M.L., Nadian A., Vipond J., Court P., Williams A., et al. Oral vaccination of guinea pigs with Mycobacterium bovis bacille Calmette-Guerin (BCG) vaccine in a lipid matrix protects against aerosol infection with virulent M. bovis. Infect Immun 76 (2008) 3771-3776
28. Nol P., Palmer M.V., Waters W.R., Aldwell F.E., Buddle B.M., Triantis J.M., et al. Efficacy of oral and parenteral routes of Mycobacterium bovis bacille Calmette-Guerin vaccination against experimental bovine tuberculosis in white-tailed deer (Odocoileus virginianus): a feasibility study. J Wildl Dis 44 (2008) 247-259
29. Chambers M.A., Wright D.C., Brisker J., Williams A., Hatch G., Gavier-Widén D., et al. A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome) protects guinea pigs from lethal tuberculosis. Vaccine 25 (2004) 1063-1071
30. McMurray D.N. Impact of nutritional deficiencies on resistance to experimental pulmonary tuberculosis. Nutr Rev 56 (1998) S147-S152
31. McMurray D.N., Carlomagno M.A., Mintzer C.L., and Tetzlaff C.L. Mycobacterium bovis BCG vaccine fails to protect protein-deficient guinea pigs against respiratory challenge with virulent Mycobacterium tuberculosis H37Rv. Infect Immun 50 (1985) 555-559
32. de Lisle G.W., Wards B.J., Buddle B.M., and Collins D.M. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium. Tuberculosis (Edinb) 85 (2005) 73-79
33. Rupprecht C.E., Hanlon C.A., and Slate D. Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control. Dev Biol (Basel) 119 (2004) 173-184